US Patent Issued to UNIVERSITE DE BRETAGNE OCCIDENTALE, UNIVERSITE DE TOURS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE on Sept. 8 for "Glycolipids and use thereof as SK3 ion channel modulators" (French Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,218, issued on Sept. 8, was assigned to UNIVERSITE DE BRETAGNE OCCIDENTALE (Brest, France), UNIVERSITE DE TOURS (Tours, France), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris) and INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris).

"Glycolipids and use thereof as SK3 ion channel modulators" was invented by Paul Alain Jaffres (Bohars, France), Helene Couthon (Bohars, France), Charlotte Sevrain (Douarnenez, France), Alicia Bauduin (Brest, France), Christophe Vandier (La Riche, France), Aurelie Chantome (Tours, France) and Delphine Fontaine (Tours, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "New glycolipids derivatives of...